Yaorong Peng

P.R. China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Spatial profiling defines three immunophenotypes and a perineural invasion-associated immune-evasion niche in gallbladder cancer.

Spatial profiling defines three immunophenotypes and a perineural invasion-associated immune-evasion niche in gallbladder cancer.

Journal: JHEP reports : innovation in hepatology

Published: July 16, 2025

Extracellular Volume Fraction Combined With Pathological Features of α-SMA and FAP for Predicting the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma After Surgery and Evaluating the Efficacy of Chemotherapy.

Extracellular Volume Fraction Combined With Pathological Features of α-SMA and FAP for Predicting the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma After Surgery and Evaluating the Efficacy of Chemotherapy.

Journal: Cancer medicine

Published: March 26, 2025

Correction to: Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.

Correction to: Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.

Journal: Journal of translational medicine

Published: January 30, 2024

Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.

Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.

Journal: Journal of translational medicine

Published: August 02, 2023

Correction to: CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer.

Correction to: CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: September 01, 2022

Immune Checkpoint Inhibitor-Based Systemic Therapy Shows Remarkable Curative Effect in a Hepatocellular Carcinoma Patient With Intractable Postoperative Recurrence and Metastases: A Case Report and Literature Review.

Immune Checkpoint Inhibitor-Based Systemic Therapy Shows Remarkable Curative Effect in a Hepatocellular Carcinoma Patient With Intractable Postoperative Recurrence and Metastases: A Case Report and Literature Review.

Journal: Frontiers in oncology

Published: September 27, 2021

Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

Journal: Cell death & disease

Published: August 17, 2021

SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.

Journal: Cell death & disease

Published: September 29, 2020

circFOXM1 contributes to sorafenib resistance of hepatocellular carcinoma cells by regulating MECP2 via miR-1324.

circFOXM1 contributes to sorafenib resistance of hepatocellular carcinoma cells by regulating MECP2 via miR-1324.

Journal: Molecular therapy. Nucleic acids

Published: September 04, 2020

PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer.

PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer.

Journal: Experimental & molecular medicine

Published: April 22, 2019

CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer.

CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: September 19, 2018

Effect of lincRNA-p21 targeting HIF-1α on biological functions of liver cancer cells.

Effect of lincRNA-p21 targeting HIF-1α on biological functions of liver cancer cells.

Journal: Oncology letters

Published: March 28, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026